Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype - ScienceDirect
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
Biomolecules | Free Full-Text | p53's Extended Reach: The Mutant p53 Secretome
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
Rare Mutation of TP53 Gene Leaves People at Higher Risk for Multiple Cancers - Penn Medicine
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
The p53 Protein: Mutations, Cancer & Cell Signalling - Assay Genie
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
Clinical implications of subclonal TP53 mutations in acute myeloid leukemia | Haematologica
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway: Cell
TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram
Pathogenesis of TP53-mutated Acute Myeloid leukemia | Laboratory of Daniel C. Link, M.D. | Washington University in St. Louis
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
Development of TP53 mutations over the course of therapy for acute myeloid leukemia - Alwash - 2021 - American Journal of Hematology - Wiley Online Library
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
IJMS | Free Full-Text | Do Mutations Turn p53 into an Oncogene?
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery
Frontiers | A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
Gaining insights into relevance across cancers based on mutation features of TP53 gene - ScienceDirect
![Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/8261/1/fig-1-full.png "Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]")
Significance of TP53 mutation in bladder cancer disease progression and drug selection [PeerJ]
